BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 9556058)

  • 1. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.
    Luckman SP; Hughes DE; Coxon FP; Graham R; Russell G; Rogers MJ
    J Bone Miner Res; 1998 Apr; 13(4):581-9. PubMed ID: 9556058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates.
    van beek E; Löwik C; van der Pluijm G; Papapoulos S
    J Bone Miner Res; 1999 May; 14(5):722-9. PubMed ID: 10320520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.
    Fisher JE; Rogers MJ; Halasy JM; Luckman SP; Hughes DE; Masarachia PJ; Wesolowski G; Russell RG; Rodan GA; Reszka AA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):133-8. PubMed ID: 9874784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.
    Frith JC; Rogers MJ
    J Bone Miner Res; 2003 Feb; 18(2):204-12. PubMed ID: 12568397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages.
    Luckman SP; Coxon FP; Ebetino FH; Russell RG; Rogers MJ
    J Bone Miner Res; 1998 Nov; 13(11):1668-78. PubMed ID: 9797474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
    Coxon FP; Helfrich MH; Van't Hof R; Sebti S; Ralston SH; Hamilton A; Rogers MJ
    J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase.
    Reszka AA; Halasy-Nagy JM; Masarachia PJ; Rodan GA
    J Biol Chem; 1999 Dec; 274(49):34967-73. PubMed ID: 10574973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effects of bisphosphonates on the osteoclast mevalonate pathway.
    Fisher JE; Rodan GA; Reszka AA
    Endocrinology; 2000 Dec; 141(12):4793-6. PubMed ID: 11108295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates: from the laboratory to the clinic and back again.
    Russell RG; Rogers MJ
    Bone; 1999 Jul; 25(1):97-106. PubMed ID: 10423031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
    Dunford JE; Thompson K; Coxon FP; Luckman SP; Hahn FM; Poulter CD; Ebetino FH; Rogers MJ
    J Pharmacol Exp Ther; 2001 Feb; 296(2):235-42. PubMed ID: 11160603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases.
    Dunford JE; Rogers MJ; Ebetino FH; Phipps RJ; Coxon FP
    J Bone Miner Res; 2006 May; 21(5):684-94. PubMed ID: 16734383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.
    Bergstrom JD; Bostedor RG; Masarachia PJ; Reszka AA; Rodan G
    Arch Biochem Biophys; 2000 Jan; 373(1):231-41. PubMed ID: 10620343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JBMR anniversary classic. Nitrogen-containing biophosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. Originally published in Volume 7, number 4, pp 581-9 (1998).
    Luckman SP; Hughes DE; Coxon FP; Russell GG; Rogers MJ
    J Bone Miner Res; 2005 Jul; 20(7):1265-74. PubMed ID: 16050006
    [No Abstract]   [Full Text] [Related]  

  • 14. Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs.
    Coxon FP; Benford HL; Russell RG; Rogers MJ
    Mol Pharmacol; 1998 Oct; 54(4):631-8. PubMed ID: 9765505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro.
    Benford HL; McGowan NW; Helfrich MH; Nuttall ME; Rogers MJ
    Bone; 2001 May; 28(5):465-73. PubMed ID: 11344045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages.
    Coxon FP; Helfrich MH; Larijani B; Muzylak M; Dunford JE; Marshall D; McKinnon AD; Nesbitt SA; Horton MA; Seabra MC; Ebetino FH; Rogers MJ
    J Biol Chem; 2001 Dec; 276(51):48213-22. PubMed ID: 11581260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis.
    Halasy-Nagy JM; Rodan GA; Reszka AA
    Bone; 2001 Dec; 29(6):553-9. PubMed ID: 11728926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphonocarboxylate inhibitors of Rab geranylgeranyl transferase disrupt the prenylation and membrane localization of Rab proteins in osteoclasts in vitro and in vivo.
    Coxon FP; Ebetino FH; Mules EH; Seabra MC; McKenna CE; Rogers MJ
    Bone; 2005 Sep; 37(3):349-58. PubMed ID: 16006204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the molecular mechanisms of action of bisphosphonates.
    Rogers MJ
    Curr Pharm Des; 2003; 9(32):2643-58. PubMed ID: 14529538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.